Home » Topics » Regulatory

Regulatory
RSS

New Videx capsule formulation approved in France

Feb. 25, 2000

Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis

Feb. 24, 2000

Nastech's NDA for intranasal scopolamine not accepted for filing

Feb. 24, 2000

Pregabalin now claimed for renal colic-associated pain

Feb. 24, 2000

New antiepileptic Diastat available in Canada for ARS

Feb. 23, 2000

GABA analogues useful for insomnia

Feb. 22, 2000

Small patient study indicates potential of baclofen in treating alcoholism

Feb. 22, 2000

FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers

Feb. 18, 2000

Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions

Feb. 17, 2000

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026